Shopping Cart
Remove All
Your shopping cart is currently empty
Raxibacumab (ABthrax) is a humanized antibody targeting the protective antigen of Bacillus anthracis, with anti-infective activity, blocking the interaction of anthrax protective antigen with its receptor. It is used in studies of anthrax disease prevention.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Raxibacumab (ABthrax) is a humanized antibody targeting the protective antigen of Bacillus anthracis, with anti-infective activity, blocking the interaction of anthrax protective antigen with its receptor. It is used in studies of anthrax disease prevention. |
| In vivo | Raxibacumab (150 or 300μg/kg, intravenously) treated a rat model first exposed to anthrax lethal toxin (LeTx) and significantly improved outcomes in rats. [1] |
| Synonyms | PAmAb, ABthrax |
| Cas No. | 565451-13-0 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.